Effectiveness of antihyperlipidemic drug management in clinical practice
- 30 November 1999
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 21 (11) , 1973-1987
- https://doi.org/10.1016/s0149-2918(00)86743-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- Persistence of Use of Lipid-Lowering MedicationsJAMA, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Cholesterol Lowering and the Use of Healthcare ResourcesCirculation, 1996
- Discontinuations of antihyperlipidemic drug therapy: assessment by means of automated databasesPharmacoepidemiology and Drug Safety, 1996
- Drug therapy for hypercholesterolemia in patients with cardiovascular disease: Factors limiting achievement of lipid goalsThe American Journal of Medicine, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Discontinuation of Antihyperlipidemic Drugs — Do Rates Reported in Clinical Trials Reflect Rates in Primary Care Settings?New England Journal of Medicine, 1995
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984